Literature DB >> 22479049

Pediatric pharmacokinetics of vancomycin: a canadian perspective.

Anais Delicourt1, Jean-François Bussières, Denis Lebel.   

Abstract

Entities:  

Year:  2011        PMID： 22479049      PMCID： PMC3093428          DOI： 10.4212/cjhp.v64i2.1004

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  8 in total

Review 1.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Am J Health Syst Pharm       Date:  2009-01-01       Impact factor: 2.637

2.  Special considerations for monitoring vancomycin concentrations in pediatric patients.

Authors:  M V Miles; L Li; H Lakkis; J Youngblood; P McGinnis
Journal:  Ther Drug Monit       Date:  1997-06       Impact factor: 3.681

3.  Vancomycin population pharmacokinetics in neonates.

Authors:  M de Hoog; R C Schoemaker; J W Mouton; J N van den Anker
Journal:  Clin Pharmacol Ther       Date:  2000-04       Impact factor: 6.875

4.  Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.

Authors:  M L Glover; E Cole; J Wolfsdorf
Journal:  J Crit Care       Date:  2000-03       Impact factor: 3.425

5.  Should higher vancomycin trough levels be targeted for invasive community-acquired methicillin-resistant Staphylococcus aureus infections in children?

Authors:  Natalia Jimenez-Truque; Isaac Thomsen; Elizabeth Saye; C Buddy Creech
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

6.  Pharmacokinetic comparison of nomogram-based and individualized vancomycin regimens in neonates.

Authors:  Trey Crumby; Eliza Rinehart; Mollie Cannon Carby; David Kuhl; Ajay J Talati
Journal:  Am J Health Syst Pharm       Date:  2009-01-15       Impact factor: 2.637

7.  Dose regimen for vancomycin not needing serum peak levels?

Authors:  W-H Tan; N Brown; A W Kelsall; R J McClure
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747

8.  Population pharmacokinetics of vancomycin in neonates.

Authors:  R E Seay; R C Brundage; P D Jensen; C G Schilling; B E Edgren
Journal:  Clin Pharmacol Ther       Date:  1994-08       Impact factor: 6.875
  8 in total
  2 in total

1.  Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.

Authors:  Kannan Sridharan; Amal Al Daylami; Reema Ajjawi; Husain Al-Ajooz; Sindhan Veeramuthu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

2.  Survey of Therapeutic Drug Monitoring Practices in Pediatric Health Care Programs across Canada.

Authors:  Donna Leung; Mary H H Ensom; Roxane Carr
Journal:  Can J Hosp Pharm       Date:  2018-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.